Cargando…
The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study
Background: At an Internal Medicine outpatient clinic, patients are referred to a weight loss service by their primary care physician to be managed by a clinical pharmacist and dietician. Objective: A study was conducted to determine the impact of this established, interdisciplinary, pharmacist-driv...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401365/ https://www.ncbi.nlm.nih.gov/pubmed/36033119 http://dx.doi.org/10.24926/iip.v12i4.4356 |
_version_ | 1784772952674271232 |
---|---|
author | Francis, Beverly R. Challen, Laura M. |
author_facet | Francis, Beverly R. Challen, Laura M. |
author_sort | Francis, Beverly R. |
collection | PubMed |
description | Background: At an Internal Medicine outpatient clinic, patients are referred to a weight loss service by their primary care physician to be managed by a clinical pharmacist and dietician. Objective: A study was conducted to determine the impact of this established, interdisciplinary, pharmacist-driven weight loss service on percent weight loss from baseline in patients who are obese or overweight compared to those receiving standard weight loss care. Methods: This was a retrospective, single-center, cohort study including adults ≥18 years of age with BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity such as hypertension, dyslipidemia, or type 2 diabetes mellitus, and referred to the clinic’s weight loss service or managed by their primary care physician. The primary outcome was percent weight loss from baseline. Key secondary outcomes included number of patients who had >5% weight loss in 6 months, number of patients who received liraglutide after 6 months, and percent weight loss in patients prescribed liraglutide. Statistical analysis included descriptive statistics, t-test for continuous outcomes, and chi-square test for between-group differences. Results: A total of 86 patients met inclusion criteria with 43 patients in the weight loss service group (intervention) and 43 patients in the primary care group (standard care). The intervention group had a significantly higher baseline weight and BMI than the standard care group (120.44 kg vs. 95.72 kg, p <0.001 and 45.34 kg/m(2) vs. 37.62 kg/m(2), p <0.001 respectively). The percent change in weight from baseline in the intervention group was a decrease of 3% compared to a decrease of 0.35% in the standard care group (p=0.03). Conclusions: Involvement of clinical pharmacist in interdisciplinary weight loss management through pharmacotherapy and other medication related services, shows considerable improvement in weight loss, when compared to the standard care of weight management. However, prospective randomized studies are warranted to further assess the benefits of a pharmacist-driven, interdisciplinary weight loss service. |
format | Online Article Text |
id | pubmed-9401365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | University of Minnesota Libraries Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-94013652022-08-25 The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study Francis, Beverly R. Challen, Laura M. Innov Pharm Original Research Background: At an Internal Medicine outpatient clinic, patients are referred to a weight loss service by their primary care physician to be managed by a clinical pharmacist and dietician. Objective: A study was conducted to determine the impact of this established, interdisciplinary, pharmacist-driven weight loss service on percent weight loss from baseline in patients who are obese or overweight compared to those receiving standard weight loss care. Methods: This was a retrospective, single-center, cohort study including adults ≥18 years of age with BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity such as hypertension, dyslipidemia, or type 2 diabetes mellitus, and referred to the clinic’s weight loss service or managed by their primary care physician. The primary outcome was percent weight loss from baseline. Key secondary outcomes included number of patients who had >5% weight loss in 6 months, number of patients who received liraglutide after 6 months, and percent weight loss in patients prescribed liraglutide. Statistical analysis included descriptive statistics, t-test for continuous outcomes, and chi-square test for between-group differences. Results: A total of 86 patients met inclusion criteria with 43 patients in the weight loss service group (intervention) and 43 patients in the primary care group (standard care). The intervention group had a significantly higher baseline weight and BMI than the standard care group (120.44 kg vs. 95.72 kg, p <0.001 and 45.34 kg/m(2) vs. 37.62 kg/m(2), p <0.001 respectively). The percent change in weight from baseline in the intervention group was a decrease of 3% compared to a decrease of 0.35% in the standard care group (p=0.03). Conclusions: Involvement of clinical pharmacist in interdisciplinary weight loss management through pharmacotherapy and other medication related services, shows considerable improvement in weight loss, when compared to the standard care of weight management. However, prospective randomized studies are warranted to further assess the benefits of a pharmacist-driven, interdisciplinary weight loss service. University of Minnesota Libraries Publishing 2021-09-22 /pmc/articles/PMC9401365/ /pubmed/36033119 http://dx.doi.org/10.24926/iip.v12i4.4356 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Francis, Beverly R. Challen, Laura M. The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study |
title | The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study |
title_full | The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study |
title_fullStr | The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study |
title_full_unstemmed | The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study |
title_short | The Impact of a Clinical Pharmacist in an Interdisciplinary Weight Loss Service: A Follow-Up Study |
title_sort | impact of a clinical pharmacist in an interdisciplinary weight loss service: a follow-up study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401365/ https://www.ncbi.nlm.nih.gov/pubmed/36033119 http://dx.doi.org/10.24926/iip.v12i4.4356 |
work_keys_str_mv | AT francisbeverlyr theimpactofaclinicalpharmacistinaninterdisciplinaryweightlossserviceafollowupstudy AT challenlauram theimpactofaclinicalpharmacistinaninterdisciplinaryweightlossserviceafollowupstudy AT francisbeverlyr impactofaclinicalpharmacistinaninterdisciplinaryweightlossserviceafollowupstudy AT challenlauram impactofaclinicalpharmacistinaninterdisciplinaryweightlossserviceafollowupstudy |